141 related articles for article (PubMed ID: 26174437)
21. Tumor dose response to the vascular disrupting agent, 5,6-dimethylxanthenone-4-acetic acid, using in vivo magnetic resonance spectroscopy.
McPhail LD; Chung YL; Madhu B; Clark S; Griffiths JR; Kelland LR; Robinson SP
Clin Cancer Res; 2005 May; 11(10):3705-13. PubMed ID: 15897567
[TBL] [Abstract][Full Text] [Related]
22. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
23. NMR monitoring of the anaerobic metabolism of frog muscle at rest.
Gussoni M; Giuliani AM; Ripamonti A; Boicelli CA
Physiol Chem Phys Med NMR; 1990; 22(4):233-40. PubMed ID: 2101936
[TBL] [Abstract][Full Text] [Related]
24. [Experimental studies on evaluation of the effects of radiotherapy and chemotherapy in urogenital tumors using 31P-magnetic resonance spectroscopy].
Kanimoto Y; Suzuki Y; Okada K
Hinyokika Kiyo; 1994 Apr; 40(4):295-301. PubMed ID: 8191967
[TBL] [Abstract][Full Text] [Related]
25. Early effects of radiotherapy in small cell lung cancer xenografts monitored by 31P magnetic resonance spectroscopy and biochemical analysis.
Kristjansen PE; Pedersen EJ; Quistorff B; Elling F; Spang-Thomsen M
Cancer Res; 1990 Aug; 50(16):4880-4. PubMed ID: 2165849
[TBL] [Abstract][Full Text] [Related]
26. 31P NMR spectroscopy can predict the optimum interval between fractionated irradiation doses.
Murata O; Sakurai H; Mitsuhashi N; Hasegawa M; Yamakawa M; Kurosaki H; Hayakawa K; Niibe H
Anticancer Res; 1998; 18(6A):4297-301. PubMed ID: 9891481
[TBL] [Abstract][Full Text] [Related]
27. Estradiol induction of retinoic acid receptors in human breast cancer cells.
Roman SD; Ormandy CJ; Manning DL; Blamey RW; Nicholson RI; Sutherland RL; Clarke CL
Cancer Res; 1993 Dec; 53(24):5940-5. PubMed ID: 8261407
[TBL] [Abstract][Full Text] [Related]
28. Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance.
Bates SE; Davidson NE; Valverius EM; Freter CE; Dickson RB; Tam JP; Kudlow JE; Lippman ME; Salomon DS
Mol Endocrinol; 1988 Jun; 2(6):543-55. PubMed ID: 3047554
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
30. Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity.
Likhite VS; Stossi F; Kim K; Katzenellenbogen BS; Katzenellenbogen JA
Mol Endocrinol; 2006 Dec; 20(12):3120-32. PubMed ID: 16945990
[TBL] [Abstract][Full Text] [Related]
31. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Nutr Cancer; 2007; 58(2):162-70. PubMed ID: 17640162
[TBL] [Abstract][Full Text] [Related]
32. Estrogenic regulation of host immunity against an estrogen receptor-negative human breast cancer.
Curran EM; Judy BM; Duru NA; Wang HQ; Vergara LA; Lubahn DB; Estes DM
Clin Cancer Res; 2006 Oct; 12(19):5641-7. PubMed ID: 17000652
[TBL] [Abstract][Full Text] [Related]
33. Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal tumor model.
Seierstad T; Røe K; Olsen DR
Radiother Oncol; 2007 Nov; 85(2):187-94. PubMed ID: 17937968
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging.
Canese R; Pisanu ME; Mezzanzanica D; Ricci A; Paris L; Bagnoli M; Valeri B; Spada M; Venditti M; Cesolini A; Rodomonte A; Giannini M; Canevari S; Podo F; Iorio E
NMR Biomed; 2012 Apr; 25(4):632-42. PubMed ID: 22020805
[TBL] [Abstract][Full Text] [Related]
35. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol.
Jacobson HI; Bennett JA; Mizejewski GJ
Cancer Res; 1990 Jan; 50(2):415-20. PubMed ID: 1688512
[TBL] [Abstract][Full Text] [Related]
37. Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers.
Giskeødegård GF; Lundgren S; Sitter B; Fjøsne HE; Postma G; Buydens LM; Gribbestad IS; Bathen TF
NMR Biomed; 2012 Nov; 25(11):1271-9. PubMed ID: 22407957
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
[TBL] [Abstract][Full Text] [Related]
39. Human hydroxysteroid (17-beta) dehydrogenase 1 expression enhances estrogen sensitivity of MCF-7 breast cancer cell xenografts.
Husen B; Huhtinen K; Saloniemi T; Messinger J; Thole HH; Poutanen M
Endocrinology; 2006 Nov; 147(11):5333-9. PubMed ID: 16916945
[TBL] [Abstract][Full Text] [Related]
40. Metabolic disturbances during short exercises in dermatomyositis revealed by real-time functional 31P magnetic resonance spectroscopy.
Pfleiderer B; Lange J; Loske KD; Sunderkötter C
Rheumatology (Oxford); 2004 Jun; 43(6):696-703. PubMed ID: 15054156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]